Global Medicated Skin Care Products Market to Reach $6.1 Billion by 2012, According to New Report by Global Industry Analysts, Inc.

Share Article

With focus pitched on maintaining the healthy and youthful appearance of skin, rising impetus on preventive skin care is surging among the young and old alike. Driven by favorable trends, the market for medical skin care products is projected to be $6.1 billion by 2012.

Medicated Skin Care Products: A Global Strategic Business Report

Medicated skin care products connote a very high-perceived value in consumer mindsets, owing to their abilities of enhancing visual appeal of skin while also suiting varied lifestyle requirements. Consumers are increasingly wooed by the functionality of these products in effectively managing their beauty and skin care needs without adversely impacting their skin health in different work and leisure milieus. Undoubtedly, the products are riding high on this note, with consumers becoming unmindful of their higher prices, and manufacturers making every effort to provide consumers with enhanced value for money. Going forwards, product premiumization is set to fuel the market's sales. AHA flowers, antioxidants, ascophylle, bamboo extracts, camosine, tangerine, liquorice, pearl proteins, peptides with anti-oxidant properties, mineral extracts and vitamins are some of the newest ingredients that have pitched their success story in the skincare world. With enhanced functionality, naturally, skincare products have shunned the confines of beauty world, and transcended their image to form a part of the ever-growing healthcare products market.

The global market for medicated skin care products is forecast to rise to US$6.1 billion by 2012, as stated by Global Industry Analysts, Inc. Asia-Pacific is the fastest growing market with a CAGR of about 11.6% through 2010. United States is the largest market and is projected to log sales of about US$2.9 billion by 2015. Europe is the second largest regional market forecast to be worth US$1.8 billion in 2013.

The market is highly fragmented with numerous products catering to diverse customer base and requirements. Market participants include Allergan, avVaa World Health Care Products, Blistex, CCA Industries, Chattem, FNC Medical Corporation, Galderma Pharma SA, Henkel, Johnson & Johnson/Neutrogena Corp, Novartis AG, Obagi Medical Products Inc, Procter & Gamble Company, Reckitt Benckiser Plc, Rohto Pharmaceutical/Mentholatum, Stiefel Laboratories, Schering-Plough Corp, Shiseido Co Ltd, Unilever NV and Wyeth Corp.

The report titled "Medicated Skin Care Products: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of market trends and issues, product overview, product introductions/innovations, and recent industry activity. The study also analyzes market data and analytics for major geographic regions including United States, Canada, Japan, Europe, Asia-Pacific, and Latin America. The report offers data analytics for the period 2001-2015, as well as historic review for 1991-2000.

For more details about this research report, please visit
http://www.strategyr.com/Medicated_Skin_Care_Products_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press @ StrategyR.com
Web Site http://www.strategyr.com/

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website